News
42mon MSN
Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke ...
The TV personality, 71 - who once topped the scales at 237lbs in 1992 - finally reached her 160lb goal weight in 2023 after ...
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Amanda Bynes posted a short video where she discussed several life updates, including plans to dye her hair and start taking ...
In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...
Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk’s hot-selling diabetes and weight-loss drugs in China due to local competition, a senior executive said.
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and ...
She began using Wegovy, the version of Ozempic approved for weight loss, after struggling with obesity. She reveals which foods to avoid on a GLP-1 and how to prevent muscle loss.
As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants to bring them back.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results